Julia Reichelt

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 11, 2022
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.

Katharina Woess, Yuchen Sun, Hanae Morio

|Dec 30, 2020
Advancing novel therapies for ichthyoses.

M Schmuth, J Reichelt, R Gruber

|Sep 12, 2020
Gene expression is stable in a complete CIB1 knockout keratinocyte model.

Elias Imahorn, Magomet Aushev, Stefan Herms

|May 30, 2019
Epidermolysis bullosa: Advances in research and treatment.

Christine Prodinger, Julia Reichelt, Johann W Bauer

|Sep 09, 2018
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.

Christina Guttmann-Gruber, Birgit Tockner, Cornelia Scharler

|Aug 13, 2018
An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.

P Peking, J S Breitenbach, M Ablinger

Pageof 2

Frequent Collaborators

2 joint publications

Verena Wally

2 joint publications

Ulrich Koller

1 joint publications

P Peking

1 joint publications

M Schmuth